Osteoporosis: Review of guidelines and consensus statements

American Journal of Managed Care

Volumn 3, Issue 7, 1997, Pages 1077-1084

  Amarshi, Naseem ^b   Scoggin, J Allen ^a   Ensworth, Stephanie ^c  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b ARKANSAS STATE UNIVERSITY   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CONSENSUS DEVELOPMENT; CONTINUING EDUCATION; COST OF ILLNESS; DISEASE MANAGEMENT; ECONOMICS; ESTROGEN THERAPY; FEMALE; HUMAN; MIDDLE AGED; OSTEOPOROSIS; PRACTICE GUIDELINE;

ADOLESCENT; ADULT; CHILD; CONSENSUS DEVELOPMENT CONFERENCES; COST OF ILLNESS; DISEASE MANAGEMENT; EDUCATION, CONTINUING; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MIDDLE AGED; OSTEOPOROSIS; PRACTICE GUIDELINES;

EID: 0031179020     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Christiansen C. Introduction: Consensus Development Conference, Hong Kong, April 1993. Am J Med 1993; 95:1S.
2. Draper MW. The osteoporosis global medical conference. Calcif Tissue Int 1996;59(suppl 1):S1.
3. Progress Report: 1996 World Congress on Osteoporosis. Amsterdam, Netherlands; May 22, 1996.
4. Consensus Development Statement: European Foundation for Osteoporosis and the National Osteoporosis Foundation (USA). Osteoporosis Int 1997;7:1-6.
5. Raymond SC. Osteoporosis: Impact on health and society. Consult Pharm 1996;11(suppl B):3-5.
6. Tennessee House Bill No. 592; Senate Bill No. 930.
7. Eastman P. Scientists finding new ways to prevent, fight osteoporosis. AARP Bull 1997;38:1,8-9.
8. Abbott TA, Lawrence BJ, Wallach S. Osteoporosis: The need for comprehensive treatment guidelines. Clin Ther 1996;18:127-149.
9. Melton LJ. Epidemiology of fractures. In: Riggs LB, Melton LJ, eds. Osteoporosis: Etiology, Diagnosis, and Management. 2nd ed. Philadelphia: Lippincott-Raven Press, 1995:225-247.
10. Reginster JYL. Harmonization of clinical practice guidelines for the prevention and treatment of osteoporosis and osteopenia in Europe. Calcif Tissue Int 1996;59(suppl 1): S24-S29.
11. Johnson CC. Clinical guidelines for the treatment of osteoporosis in Japan. Calcif Tissue Int 1996;59(suppl 1): S30-S33.
12. Raisz LG. The osteoporosis revolution. Ann Intern Med 1997;126:458-462.
13. Riggs LB. Osteoporosis. In: Wyngaarden JB, Smith LH, Bennett JC, eds. Cecil Textbook of Medicine. 19th ed. Philadelphia: WB Saunders and Company; 1992:1426-1431.
14. Consensus Development Conference. Diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 1993; 94:646-650.
15. Schneider EL, Guralnik JM. The aging of America: Impact on health care costs. JAMA 1990;263:2335-2340.
16. Josee RG. Effects of ovarian hormone therapy on skeletal and extraskeletal tissues in women. Can Med Assoc J 1996; 155:929-934.
17. American Association of Clinical Endocrinologists. AACE Clinical Practice Guidelines for the Prevention and Treatment of Postmenopausal Osteoporosis. Endocr Pract 1996;2:155-171.
18. Hanley DA, Josse RG. Prevention and management of osteoporosis: Consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. Can Med Assoc J 1996;155:921-922.
19. Melton LJ, Eddy DM, Johnson CC. Screening for osteoporosis. Ann Intern Med 1990;112:516-528.
20. American College of Physicians. Screening for Osteoporosis in Perimenopausal Women, July 1990.
21. Bilger B. Osteoporosis. Hippocrates May 1996:67-69.
22. Johnson CC, Melton LJ. Bone densitometry. In: Riggs LB, Melton LJ, eds. Osteoporosis: Etiology, Diagnosis, and Management. 2nd ed. Philadelphia: Lippincott-Raven Press, 1995:275-296.
23. Anonymous. Bone densitometry. Med Lett 1996; 38:103-104.
24. American College of Rheumatology, task force on osteoporosis guidelines. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheum 1996;39:1791-1801.
25. Sturtridge W, Lentle B, Hanley DA. The use of bone density measurement in the diagnosis and management of osteoporosis. Can Med Assoc J 1996; 155:924-929.
26. Avioli LV. New developments in osteoporosis pharmacology. Consult Pharm 1996;11(suppl B):12-17.
27. Prince RL. Practice guidelines for the treatment of osteoporosis. Calcif Tissue Int 1996;59(suppl 1):S20-S23.
28. Prior JC, Barr SI, Chow R, et al. Use of bisphosphonates in the treatment of osteoporosis. Can Med Assoc J 1996; 155:940-944.
29. Murray TM. Calcium nutrition and osteoporosis. Can Med Assoc J 1996;155:935-939.
30. Murray TM. Fluoride therapy for osteoporosis. Can Med Assoc J 1996;155:949-953.
31. National Osteoporosis Foundation. NOF Osteoporosis Clinical Practice Guideline Publications. Washington, DC; 1997.